The Mortality and Myocardial Effects of Antidepressants Are Moderated by Preexisting Cardiovascular Disease: A Meta-Analysis
The DOI matches its Crossref record; 95 of the 96 references it cites were found in a registry or an index.
Abstract
Background: Antidepressants (ADs) are commonly prescribed medications, but their long-term health effects are debated. ADs disrupt multiple adaptive processes regulated by evolutionarily ancient biochemicals, potentially increasing mortality. However, many ADs also have anticlotting properties that can be efficacious in treating cardiovascular disease. We conducted a meta-analysis assessing the effects of ADs on all-cause mortality and cardiovascular events in general-population and cardiovascular-patient samples. Methods: Two reviewers independently assessed articles from PubMed, EMBASE, and Google Scholar for AD-related mortality controlling for depression and other comorbidities. From these articles, we extracted information about cardiovascular events, cardiovascular risk status, and AD class. We conducted mixed-effect meta-analyses testing sample type and AD class as moderators of all-cause mortality and new cardiovascular events. Results: Seventeen studies met our search criteria. Sample type consistently moderated health risks. In general-population samples, AD use increased the risks of mortality (HR = 1.33, 95% CI: 1.14-1.55) and new cardiovascular events (HR = 1.14, 95% CI: 1.08-1.21). In cardiovascular patients, AD use did not significantly affect risks. AD class also moderated mortality, but the serotonin reuptake inhibitors were not significantly different from tricyclic ADs (TCAs) (HR = 1.10, 95% CI: 0.93-1.31, p = 0.27). Only “other ADs” were differentiable from TCAs (HR = 1.35, 95% CI: 1.08-1.69). Mortality risk estimates increased when we analyzed the subset of studies controlling for premedication depression, suggesting the absence of confounding by indication. Conclusions: The results support the hypothesis that ADs are harmful in the general population but less harmful in cardiovascular patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The substantial correlation between various somatic symptoms speaks to a neurophysiological basis for PWS, possibly autonomic nervous system dysfunction.25,54,55”
From Protracted withdrawal syndrome after stopping antidepressants: a descriptive quantitative analysis of consumer narratives from a large internet forum (2020) · cites this paper as [55]
In the citing paper
“According to the recent metaanalyses, antidepressants' use was associated with a 33% increase in mortality corresponding to estimated additional 2.64 deaths per 1,000 person-years.87”
From Addressing the Side Effects of Contemporary Antidepressant Drugs: A Comprehensive Review (2018) · cites this paper as [87]
In the citing paper
“Some studies have found that antidepressant use was associated with a small increase in all-cause mortality, while other meta-analysis has suggested potential differences based on population characteristics.”
From Addressing the Side Effects of Contemporary Antidepressant Drugs: A Comprehensive Review (2018) · cites this paper as [87]
In the citing paper
“Similarily, the class effects of antidepressants on all cause mortality are also still elusive, although the widespread use of SSRIs is partly based on the belief that they are safer than the older TCAs.87”
From Addressing the Side Effects of Contemporary Antidepressant Drugs: A Comprehensive Review (2018) · cites this paper as [87]
In the citing paper
“Antidepressants may be hazardous in the general population, but are less so in cardiovascular patients, perhaps owing to the positive effects in the clotting process involving platelet cell activation.8789”
From Addressing the Side Effects of Contemporary Antidepressant Drugs: A Comprehensive Review (2018) · cites this paper as [87]
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Conducting Meta-Analyses in R with the metafor Package
Viechtbauer, W. (2010) · Journal of Statistical Software · doi:10.18637/jss.v036.i03 · Cited by 20,464
Downs, S. H., & Black, N. (1998) · Journal of Epidemiology and Community Health · doi:10.1136/jech.52.6.377 · Cited by 8,252
Sterne, J. A. C., Sutton, A. J., Ioannidis, J. P. A., Terrin, N., Jones, D. R., Lau, J., Carpenter, J., Rucker, G., Harbord, R. M., Schmid, C. H., et al. (2011) · BMJ · doi:10.1136/bmj.d4002 · Cited by 7,709
Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1. The Cochrane Collaboration
Higgins, J. P. T., Green, S. R., & Higgins, J. P. T. (2008) · Cited by 7,226
The New Statistics: Why and How
Cumming, G. (2014) · Psychological Science · doi:10.1177/0956797613504966 · Cited by 3,200
Residuals and Influence in Regression
Ling, R. F. (1984) · Technometrics · doi:10.1080/00401706.1984.10487996 · Cited by 2,642
Platelet Activation and Atherothrombosis
Davì, G., & Patrono, C. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071014 · Cited by 2,135
Gershon, M. D., & Tack, J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.11.002 · Cited by 1,563
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I
Paneni, F., Beckman, J. A., Creager, M. A., & Cosentino, F. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht149 · Cited by 1,401
Affective disorders and suicide risk: a reexamination
Bostwick, J. M., & Pankratz, V. S. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.12.1925 · Cited by 878
Antidepressant use and risk of adverse outcomes in older people: population based cohort study
Coupland, C., Dhiman, P., Morriss, R., Arthur, A., Barton, G., & Hippisley-Cox, J. (2011) · BMJ · doi:10.1136/bmj.d4551 · Cited by 833
Depressed Affect, Hopelessness, and the Risk of Ischemic Heart Disease in a Cohort of U.S. Adults
Anda, R., Williamson, D., Jones, D., Macera, C., Eaker, E., Glassman, A., & Marks, J. (1993) · Epidemiology · doi:10.1097/00001648-199307000-00003 · Cited by 774
National Patterns in Antidepressant Medication Treatment
Olfson, M., & Marcus, S. C. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.81 · Cited by 730
Carvalho, A. F., Sharma, M. S., Brunoni, A. R., Vieta, E., & Fava, G. A. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000447034 · Cited by 650
Cardiovascular disease and chronic renal disease: A new paradigm
Sarnak, M. J., & Levey, A. S. (2000) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(00)70239-3 · Cited by 586
Frasure-Smith, N., & Lespérance, F. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.4 · Cited by 571
Epidemiology of comorbid coronary artery disease and depression
Rudisch, B., & Nemeroff, C. B. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00587-0 · Cited by 552
Safety and Efficacy of Sertraline for Depression in Patients With Heart Failure
O'Connor, C. M., Jiang, W., Kuchibhatla, M., Silva, S. G., Cuffe, M. S., Callwood, D. D., Zakhary, B., Stough, W. G., Arias, R. M., Rivelli, S. K., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.03.068 · Cited by 535
Taylor, C. B. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.7.792 · Cited by 512
Antidepressant use in persons aged 12 and over: United States, 2005-2008.
Pratt, L. A., Brody, D. J., & Gu, Q. (2011) · PubMed · Cited by 490
Cohen, S., & Pressman, S. D. (2006) · Current Directions in Psychological Science · doi:10.1111/j.0963-7214.2006.00420.x · Cited by 436
Heartache and heartbreak—the link between depression and cardiovascular disease
Nemeroff, C. B., & Goldschmidt-Clermont, P. J. (2012) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.91 · Cited by 424
Cardiovascular Side Effects of New Antidepressants and Antipsychotics: New Drugs, old Concerns?
Pacher, P., & Kecskemeti, V. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043383872 · Cited by 390
Tanaka, M., Yoshida, M., Emoto, H., & Ishii, H. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00569-0 · Cited by 382
Buckley, N. A., & McManus, P. R. (2002) · BMJ · doi:10.1136/bmj.325.7376.1332 · Cited by 380
Serotonin and Depression: A Disconnect between the Advertisements and the Scientific Literature
Lacasse, J. R., & Leo, J. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020392 · Cited by 377
Relationship of Depression to Death or Hospitalization in Patients With Heart Failure
Sherwood, A. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.4.367 · Cited by 343
Mortality and Poststroke Depression: A Placebo-Controlled Trial of Antidepressants
Jorge, R. E., Robinson, R. G., Arndt, S., & Starkstein, S. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.10.1823 · Cited by 339
Dopamine, a neurotransmitter, influences the immune system
Basu, S., & Dasgupta, P. S. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00176-9 · Cited by 335
Sharma, T., Guski, L. S., Freund, N., & Gøtzsche, P. C. (2016) · BMJ · doi:10.1136/bmj.i65 · Cited by 319
National trends in the treatment for depression from 1998 to 2007
Marcus, S. C., & Olfson, M. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.151 · Cited by 312
Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo
Von Känel, R., & Dimsdale, J. E. (2000) · European Journal of Haematology · doi:10.1034/j.1600-0609.2000.065006357.x · Cited by 311
Andrade, C., Sandarsh, S., Chethan, K. B., & Nagesh, K. S. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09r05786blu · Cited by 302
Current Psychosomatic Practice
Fava, G. A., Cosci, F., & Sonino, N. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000448856 · Cited by 302
Andrews, P. W., Bharwani, A., Lee, K. R., Fox, M., & Thomson, J. A. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.01.018 · Cited by 281
Molecular Mechanisms of SERT in Platelets: Regulation of Plasma Serotonin Levels
Mercado, C. P., & Kilic, F. (2010) · Molecular Interventions · doi:10.1124/mi.10.4.6 · Cited by 261
Proportion Of Antidepressants Prescribed Without A Psychiatric Diagnosis Is Growing
Mojtabai, R., & Olfson, M. (2011) · Health Affairs · doi:10.1377/hlthaff.2010.1024 · Cited by 256
Smoller, J. W. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.436 · Cited by 255
Depression and Cardiovascular Disorders
Whooley, M. A., & Wong, J. M. (2013) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050212-185526 · Cited by 241
Selective serotonin reuptake inhibitors and brain hemorrhage: A meta-analysis
Hackam, D. G., & Mrkobrada, M. (2012) · Neurology · doi:10.1212/wnl.0b013e318271f848 · Cited by 230
Rubí, B., & Maechler, P. (2010) · Endocrinology · doi:10.1210/en.2010-0745 · Cited by 207
Platelet Reactivity in Depressed Patients Treated With Paroxetine: Preliminary Findings
Musselman, D. L., Marzec, U. M., Manatunga, A., Penna, S., Reemsnyder, A., Knight, B. T., Baron, A., Hanson, S. R., & Nemeroff, C. B. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.9.875 · Cited by 205
Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin.
Larsson, P. T., Wallén, N. H., & Hjemdahl, P. (1994) · Circulation · doi:10.1161/01.cir.89.5.1951 · Cited by 186
Serotonin and Brain: Evolution, Neuroplasticity, and Homeostasis
Azmitia, E. C. (2006) · International review of neurobiology · doi:10.1016/s0074-7742(06)77002-7 · Cited by 175
Gallo, J. J., Bogner, H. R., Morales, K. H., Post, E. P., Lin, J. Y., & Bruce, M. L. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-10-200705150-00002 · Cited by 163
The mechanisms of tolerance in antidepressant action
Fava, G. A., & Offidani, E. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.026 · Cited by 158
Win, S., Parakh, K., Eze-Nliam, C. M., Gottdiener, J. S., Kop, W. J., & Ziegelstein, R. C. (2011) · Heart · doi:10.1136/hrt.2010.209767 · Cited by 158
Serotonin synthesis, release and reuptake in terminals: a mathematical model
Best, J., Nijhout, H. F., & Reed, M. (2010) · Theoretical Biology and Medical Modelling · doi:10.1186/1742-4682-7-34 · Cited by 152
Moncrieff, J., & Kirsch, I. (2015) · Contemporary Clinical Trials · doi:10.1016/j.cct.2015.05.005 · Cited by 142
An adaptationist perspective on the etiology of depression
Durisko, Z., Mulsant, B. H., & Andrews, P. W. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.09.032 · Cited by 140
Self-citationAntidepressant medication use and future risk of cardiovascular disease: the Scottish Health Survey
Hamer, M., Batty, G. D., Seldenrijk, A., & Kivimaki, M. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehq438 · Cited by 140
Antidepressant Use, Depression, and Survival in Patients With Heart Failure
O’Connor, C. M., Jiang, W., Kuchibhatla, M., Mehta, R. H., Clary, G. L., Cuffe, M. S., Christopher, E. J., Alexander, J. D., Califf, R. M., & Krishnan, R. R. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.20.2232 · Cited by 137
THE UPTAKE AND BINDING OF CIRCULATING SEROTONIN AND THE EFFECT OF DRUGS
Axelrod, J., & Inscoe, J. K. (1963) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)26593-4 · Cited by 133
Primum Non Nocere: An Evolutionary Analysis of Whether Antidepressants Do More Harm than Good
Andrews, P. W., Thomson, J. A., Amstadter, A., & Neale, M. C. (2012) · Frontiers in Psychology · doi:10.3389/fpsyg.2012.00117 · Cited by 120
Self-citationWong, D. T., Horng, J.-S., & Fuller, R. W. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90412-7 · Cited by 118
Khan, A., Faucett, J., Morrison, S., & Brown, W. A. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.149 · Cited by 109
Intrarenal dopamine deficiency leads to hypertension and decreased longevity in mice
Zhang, M.-Z., Yao, B., Wang, S., Fan, X., Wu, G., Yang, H., Yin, H., Yang, S., & Harris, R. C. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57324 · Cited by 108
Andrews, P. W., Kornstein, S. G., Halberstadt, L. J., Gardner, C. O., & Neale, M. C. (2011) · Frontiers in Psychology · doi:10.3389/fpsyg.2011.00159 · Cited by 107
Self-citationDoes long term use of psychiatric drugs cause more harm than good?
Gotzsche, P. C., Young, A. H., & Crace, J. (2015) · BMJ · doi:10.1136/bmj.h2435 · Cited by 104
Late-life depression and mortality: influence of gender and antidepressant use
Ryan, J., Carriere, I., Ritchie, K., Stewart, R., Toulemonde, G., Dartigues, J.-F., Tzourio, C., & Ancelin, M.-L. (2008) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.039164 · Cited by 103
Do Antidepressants Cure or Create Abnormal Brain States?
Moncrieff, J., & Cohen, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030240 · Cited by 97
Rational Use of Antidepressant Drugs
Fava, G. A. (2014) · Psychotherapy and Psychosomatics · doi:10.1159/000362803 · Cited by 95
Depression, Antidepressant Use and Mortality in Later Life: The Health in Men Study
Almeida, O. P., Alfonso, H., Hankey, G. J., & Flicker, L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011266 · Cited by 90
Depression, antidepressants, and long-term mortality in heart failure
Díez, C., Lupón, J., González, B., Urrútia, A., Cano, L., Cabanes, R., Altimir, S., Coll, R., Pascual, T., de Antonio, M., et al. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.03.143 · Cited by 87
Bupropion for Smoking Cessation in Patients With Acute Coronary Syndrome
Planer, D., Lev, I., Elitzur, Y., Sharon, N., Ouzan, E., Pugatsch, T., Chasid, M., Rom, M., & Lotan, C. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.72 · Cited by 70
Krantz, D. S., Whittaker, K. S., Francis, J. L., Rutledge, T., Johnson, B. D., Barrow, G., McClure, C., Sheps, D. S., York, K., Cornell, C., et al. (2009) · Heart · doi:10.1136/hrt.2009.176040 · Cited by 64
Fava, G. A., Guidi, J., Rafanelli, C., & Sonino, N. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000366041 · Cited by 62
Castro, V. M., Gallagher, P. J., Clements, C. C., Murphy, S. N., Gainer, V. S., Fava, M., Weilburg, J. B., Churchill, S. E., Kohane, I. S., Iosifescu, D. V., et al. (2012) · BMJ Open · doi:10.1136/bmjopen-2011-000544 · Cited by 53
Balogun, R. A., Abdel‐Rahman, E. M., Balogun, S. A., Lott, E. H., Lü, J., Malakauskas, S. M., Ma, J. Z., Kalantar‐Zadeh, K., & Kovesdy, C. P. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02650312 · Cited by 49
Biodistribution and imaging with (123)I-ADAM: a serotonin transporter imaging agent.
Newberg, A. B., Plößl, K., Mozley, P. D., Stubbs, J. B., Wintering, N., Udeshi, M., Alavi, A. A., Kauppinen, T., & Kung, H. F. (2004) · PubMed · Cited by 48
Hanash, J. A., Hansen, B. H., Hansen, J. F., Nielsen, O. W., Rasmussen, A., & Birket‐Smith, M. (2012) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3182677041 · Cited by 47
Swinkels, J. A., & de Jonghe, F. (1995) · International Clinical Psychopharmacology · doi:10.1097/00004850-199501004-00003 · Cited by 46
Lu, J. Q., Ichise, M., Liow, J. S., Ghose, S., Vines, D., & Innis, R. B. (2004) · PubMed · Cited by 43
Energy utilization by the lung
Fisher, A. B., Steinberg, H. N., & Bassett, M. (1974) · The American Journal of Medicine · doi:10.1016/0002-9343(74)90137-5 · Cited by 40
Leveraging a Critical Care Database
Ghassemi, M., Marshall, J., Singh, N., Stone, D. J., & Celi, L. A. (2014) · Chest · doi:10.1378/chest.13-1722 · Cited by 38
Biodistribution study of [123I] ADAM in mice: correlation with whole body autoradiography
Lin, K., Ye, X.-X., Yen, T., Wey, S., Tzen, K., Ting, G., & Hwang, J. (2002) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(02)00323-2 · Cited by 35
Variation in results from randomized, controlled trials: stochastic or systematic?
Jane-wit, D., Horwitz, R. I., & Concato, J. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.02.010 · Cited by 33
Flöck, A., Zobel, A. W., Bauriedel, G., Tuleta, I., Hammerstingl, C., Höfels, S., Schuhmacher, A., Maier, W., Nickenig, G., & Skowasch, D. (2010) · Thrombosis Research · doi:10.1016/j.thromres.2010.04.020 · Cited by 31
Qian, J., Simoni‐Wastila, L., LANGENBERG, P. W., Rattinger, G. B., Zuckerman, I. H., Lehmann, S. W., & Terrin, M. C. (2013) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12220 · Cited by 29
Hollon, S. D. (2015) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796015000748 · Cited by 28
Self-citationClinical Methodology Matters in Epidemiology: Not All Benzodiazepines Are the Same
Cosci, F., Guidi, J., Balon, R., & Fava, G. A. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000437201 · Cited by 27
Acharya, T., Acharya, S., Tringali, S., & Huang, J. (2013) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1311 · Cited by 27
Lin, K., Liu, C., Wey, S., Hsiao, I., Wu, J., Fu, Y.-K., & Yen, T. (2006) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2005.10.006 · Cited by 25
Gaukler, S. M., Ruff, J. S., Galland, T., Kandaris, K. A., Underwood, T. K., Liu, N. M., Young, E. L., Morrison, L. C., Yost, G. S., & Potts, W. K. (2014) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2014.11.002 · Cited by 21
23. The Illusions of Psychiatry. The New York Review of Books
Angell, M. E. (2012) · Columbia University Press eBooks · doi:10.7312/star16073-024 · Cited by 21
Misrepresenting harms in antidepressant trials
Moncrieff, J. (2016) · BMJ · doi:10.1136/bmj.i217 · Cited by 15
Yoffe, J. R., & Borchardt, R. T. (1982) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14624-5 · Cited by 11
Characterization of Serotonin Uptake in Isolated Bovine Pinealocyte Suspensions
Ducis, I., & DiStefano, V. (1980) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14534-3 · Cited by 10
Uptake and release of [3H]-serotonin in photophores of the midshipman fish, Porichthys notatus
Larivière, L., & Anctil, M. (1984) · Comparative Biochemistry and Physiology Part C Comparative Pharmacology · doi:10.1016/0742-8413(84)90075-6 · Cited by 8
Platelet Activation and "Crossover Appeal": Rab and Rho Families United by Common Links to Serotonin
Heger, C. D. (2004) · Molecular Interventions · doi:10.1124/mi.4.2.3 · Cited by 8
Systemic Manifestations and Comorbidities of Chronic Obstructive Pulmonary Disease
Most, J. F., Possick, J. D., & Rochester, C. L. (2014) · Clinical Pulmonary Medicine · doi:10.1097/cpm.0000000000000044 · Cited by 4
Cited by
Davies, J., & Read, J. (2019) · Addictive Behaviors · doi:10.1016/j.addbeh.2018.08.027 · Cited by 387
Screening and Management of Depression in Patients With Cardiovascular Disease
Jha, M. K., Qamar, A., Vaduganathan, M., Charney, D. S., & Murrough, J. W. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.01.041 · Cited by 365
“The use of antidepressant medications in patients with CVD has not been associated with increased mortality, especially after controlling for the presence of depressive symptoms (97,118,119).”
Addressing the Side Effects of Contemporary Antidepressant Drugs: A Comprehensive Review
Wang, S.-M., Han, C., Bahk, W.-M., Lee, S.-J., Patkar, A. A., Masand, P. S., & Pae, C.-U. (2018) · Chonnam Medical Journal · doi:10.4068/cmj.2018.54.2.101 · Cited by 299
“Early studies have suggested that newer antidepressants, SSRIs and SNRIs still have a risk of weight gain, but mirtazapine have less risk of causing weight gain than TCAs.67 It was generally accepted that paroxetine has a higher risk of weight gain amongst the SSRIs, and amitriptyline was thought to cause the most pot…”
BackgroundInfluentialPlacebo effect in the treatment of depression and anxiety
Kirsch, I. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00407 · Cited by 205
Antidepressive Mechanisms of Probiotics and Their Therapeutic Potential
Yong, S. J., Tong, T., Chew, J., & Lim, W. L. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01361 · Cited by 204
Metadata
- Authors
- Maslej, M. M., Bolker, B. M., Russell, M. J., Eaton, K., Durisko, Z., Hollon, S. D., Swanson, G. M., Thomson Jr., J. A., Mulsant, B. H., & Andrews, P. W.
- Affiliations
- McMaster University (CA)
- Vanderbilt University (US)
- Hamad bin Khalifa University (QA)
- Centre for Addiction and Mental Health (CA)
- ORCID
- Venue
- Psychotherapy and Psychosomatics
- Publisher
- S. Karger AG
- Published
- 2017
- Volume
- 86
- Issue
- 5
- Pages
- 268-282
- ISSN
- 0033-3190 (ISSN-L)
- 1423-0348
- OpenAlex
- W2755406504
- Cited by
- 98
- References
- 96
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 10 · 2023: 10 · 2022: 12 · 2021: 15 · 2020: 6 · 2019: 16 · 2018: 17 · 2017: 2
- FWCI
- 1.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Psychotherapy and Psychosomatics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Centre for Addiction and Mental Health
- Universiteit Maastricht
- University of California, San Francisco
- Luonnontieteiden ja Tekniikan Tutkimuksen Toimikunta
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Keywords
- antidepressants, all-cause mortality, cardiovascular events, pre-existing cardiovascular disease, tricyclic antidepressants, serotonin reuptake inhibitors, confounding by indication, depression, cardiovascular risk, adverse drug reactions
- MeSH terms
- Antidepressive Agents, Tricyclic, Cardiovascular Diseases, Depressive Disorder, Humans, Mortality, Risk Factors, Comorbidity, Selective Serotonin Reuptake Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.